How Dexcom and Abbott are moving beyond diabetes with blood sugar monitoring.

According to the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes. This is slightly more than 11% of the entire population.

A diabetic’s body does not make enough or any insulin. People suffering from this disease should monitor their blood sugar regularly. This is traditionally done with a glucometer, which diabetics use to repeatedly prick their fingers for blood drops. But over the past decade, technology like continuous glucose monitoring has been on the rise.

Abbott And Dex work There are two most dominant players in the space. Both companies have grown.

The technology is also being marketed through several health and fitness apps as many companies see benefits for people who do not have diabetes.

CNBC spoke with both Abbott and Dexcom about the technology inside continuous glucose monitors and how they see it expanding.

Watch the video to learn more.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *